Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsrheumatology-musculoskeletal-and-sports

Paeds SAQs · rheumatology-musculoskeletal-and-sports

Scleroderma, mixed connective-tissue disease and overlap syndromes: SAQ

Short-answer questions on the paediatric scleroderma, covering the distinction between the localised scleroderma (morphea) and the juvenile systemic sclerosis, the Zulian morphea classification with the linear subtype commonest, the PReS and ACR provisional criteria for the juvenile systemic sclerosis, the anti-U1-RNP overlap of the mixed connective-tissue disease, the methotrexate first-line therapy for the active localised disease, and the pulmonary arterial hypertension and the scleroderma renal crisis that drive the prognosis.

20 marks30 min4 min readVerification in progress

Target exams

RACP DWEMRCPCH TheoryABP General Pediatrics
On this page
Study tools

Target exams

RACP DWEMRCPCH TheoryABP General Pediatrics
Prompt
An eight-year-old girl is referred for a hard, shiny, ivory-coloured plaque with a violaceous lilac ring on her right forearm, present for four months and slowly enlarging. She is otherwise well, with no Raynaud phenomenon, a normal examination of the hands and the nailfolds, and a normal blood pressure. Outline how you would classify and confirm the diagnosis, then discuss the definitive management of the active localised scleroderma, and contrast it with the approach to a child with the juvenile systemic sclerosis and a child with the mixed connective-tissue disease.

This girl has the classic presentation of the juvenile localised scleroderma, the circumscribed morphea: the hard, the shiny, the ivory-coloured plaque with the violaceous lilac ring of the active inflammation, the slow enlargement, and the absence of the Raynaud phenomenon, the sclerodactyly, the nailfold changes and the internal organ involvement that would point to the systemic disease. The task is to confirm the localised diagnosis, to begin the methotrexate before the damage fixes, and to hold the contrast with the systemic sclerosis and the overlap syndrome. [6][9]

Question 1 (10 marks)

Outline how you classify and confirm the diagnosis in this eight-year-old girl with the indurated plaque. [6]

A full-mark answer places the lesion in the localised scleroderma family, names the Zulian classification subtypes, confirms the localised rather than the systemic disease, and identifies the linear subtype as the commonest and the one that harms the growing child. [8]

The classification and the family (3 marks). The lesion is the localised scleroderma (morphea), the disease confined to the skin and the subcutaneous tissue without the internal organ involvement. The Zulian classification, drawn from the seven hundred and fifty children, sorts the localised disease into five subtypes: the circumscribed morphea (the plaque, which this girl has), the linear scleroderma (the band), the generalised morphea, the pansclerotic morphea and the mixed morphea. The localised form is the commoner paediatric scleroderma and carries the better prognosis. [6]

The distinction from the systemic disease (3 marks). The absence of the Raynaud phenomenon, the sclerodactyly, the nailfold capillary changes and the internal organ involvement places the lesion in the localised family. The juvenile systemic sclerosis is defined by the proximal skin sclerosis with the internal organ disease, and it is rare in childhood. The PReS and ACR provisional criteria require the major criterion of the proximal skin sclerosis plus at least two minor criteria from the nine organ systems. The localised disease lacks these systemic features entirely. [2][1]

The confirmation and the subtype that matters (4 marks). The diagnosis of the typical morphea is clinical, with the induration, the lilac ring and the photography for the serial tracking, and the skin biopsy is reserved for the atypical lesion to exclude the mimics such as the lichen sclerosus and the eosinophilic fasciitis. The linear subtype is the commonest in children, around two-thirds, and the band that crosses a joint produces the contracture and the limb-length discrepancy, and the facial linear disease the en coup de sabre and the Parry-Romberg with the seizures and the uveitis. The fellow names the linear subtype as the one that demands the early methotrexate. [7]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References9ShowHide
  1. [1]Foeldvari I, Pain CE Juvenile systemic sclerosis Best Pract Res Clin Rheumatol, 2026.PMID 41638996
  2. [2]Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA Jr, Lehman TJ, Cerinic MM, Martini G, Ravelli A, Russo R, Cuttica R, de Oliveira SK, Denton CP, Cozzi F, Foeldvari I, Ruperto N The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis Arthritis Rheum, 2007.PMID 17330294
  3. [6]Zulian F, Athreya BH, Laxer R, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study Rheumatology (Oxford), 2006.PMID 16368732
  4. [7]Martini G, Fadanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review Autoimmun Rev, 2018.PMID 29729451
  5. [9]Kaushik A, Mahajan R, De D, et al. Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural history Clin Exp Dermatol, 2020.PMID 32449205
  6. [10]Chevalier K, Bader-Meunier B, Kone-Paut I, Terrier B, Hachulla E, Mouthon L, Chaigne B, Costedoat-Chalumeau N Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort study Semin Arthritis Rheum, 2026.PMID 41412094
  7. [5]Di Pasquale G, Caione N, Di Berardino A, et al. Pulmonary manifestations of juvenile vs. adult systemic sclerosis: insights into pathophysiological and clinical features Pediatr Pulmonol, 2025.PMID 39545645
  8. [8]Kaushik A, Mahajan R, De D, et al. Paediatric morphoea: a holistic review. Part 1: epidemiology, aetiopathogenesis and clinical classification Clin Exp Dermatol, 2020.PMID 32472964
  9. [11]John KJ, Sadiq M, George T, et al. Clinical and Immunological Profile of Mixed Connective Tissue Disease and a Comparison of Four Diagnostic Criteria Int J Rheumatol, 2020.PMID 32411251
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousRelative energy deficiency in sport and athlete nutrition — formative SAQsrheumatology-musculoskeletal-and-sportsNextScoliosis and spinal deformity — formative SAQsrheumatology-musculoskeletal-and-sports